| Ident. | Authors (with country if any) | Title |
|---|
| 000230 (2019) |
J. Zebialowicz Ahlström [Suède] ; F. Massaro [Italie] ; P. Mikolka [Suède, Slovaquie] ; R. Feinstein [Suède] ; G. Perchiazzi [Suède] ; O. Basabe-Burgos [Suède] ; T. Curstedt [Suède] ; A. Larsson [Suède] ; J. Johansson [Suède] ; A. Rising [Suède] | Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits. |
| 000244 (2019) |
Dmitrii Y. Travin [Russie] ; Zoe L. Watson [États-Unis] ; Mikhail Metelev [Russie, Suède] ; Fred R. Ward [États-Unis] ; Ilya A. Osterman [Russie] ; Irina M. Khven [Russie] ; Nelli F. Khabibullina [États-Unis, Russie] ; Marina Serebryakova [Russie] ; Peter Mergaert [France] ; Yury S. Polikanov [États-Unis] ; Jamie H D. Cate [États-Unis] ; Konstantin Severinov [Russie, États-Unis] | Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition. |
| 000706 (2018) |
Edimara S. Reis [États-Unis] ; Nadja Berger [États-Unis] ; Xin Wang [États-Unis] ; Sophia Koutsogiannaki [États-Unis] ; Robert K. Doot [États-Unis] ; Justin T. Gumas [États-Unis] ; Periklis G. Foukas [Grèce] ; Ranillo R G. Resuello [Philippines] ; Joel V. Tuplano [Philippines] ; David Kukis [États-Unis] ; Alice F. Tarantal [États-Unis] ; Anthony J. Young [États-Unis] ; Tetsuhiro Kajikawa [États-Unis] ; Athena M. Soulika [États-Unis] ; Dimitrios C. Mastellos [Grèce] ; Despina Yancopoulou [Grèce] ; Ali-Reza Biglarnia [Suède] ; Markus Huber-Lang [Allemagne] ; George Hajishengallis [États-Unis] ; Bo Nilsson [Suède] ; John D. Lambris [États-Unis] | Safety profile after prolonged C3 inhibition. |
| 000E74 (2017) |
Daria Bulanova [Finlande] ; Aleksandr Ianevski [Finlande] ; Andrii Bugai [Finlande] ; Yevhen Akimov [Finlande] ; Suvi Kuivanen [Finlande] ; Henrik Paavilainen [Finlande] ; Laura Kakkola [Finlande] ; Jatin Nandania [Finlande] ; Laura Turunen [Finlande] ; Tiina Ohman [Finlande] ; Hanna Ala-Hongisto [Finlande] ; Hanna M. Pesonen [Finlande] ; Marika S. Kuisma [Finlande] ; Anni Honkimaa [Finlande] ; Emma L. Walton [Norvège] ; Valentyn Oksenych [Norvège] ; Martina B. Lorey [Finlande] ; Dmitry Guschin [Corée du Sud] ; Jungmin Shim [Corée du Sud] ; Jinhee Kim [Corée du Sud] ; Thoa T. Than [Corée du Sud] ; So Young Chang [Corée du Sud] ; Veijo Hukkanen [Finlande] ; Evgeny Kulesskiy [Finlande] ; Varpu S. Marjomaki [Finlande] ; Ilkka Julkunen [Finlande] ; Tuula A. Nyman [Finlande, Norvège] ; Sampsa Matikainen [Finlande] ; Jani S. Saarela [Finlande] ; Famara Sane [France] ; Didier Hober [France] ; Gülsah Gabriel [Allemagne] ; Jef K. De Brabander [États-Unis] ; Miika Martikainen [Suède] ; Marc P. Windisch [Corée du Sud] ; Ji-Young Min [Corée du Sud] ; Roberto Bruzzone [Corée du Sud, République populaire de Chine, France] ; Tero Aittokallio [Finlande] ; Markus V H Koskela [Finlande] ; Olli Vapalahti [Finlande] ; Arto Pulk [Estonie] ; Vidya Velagapudi [Finlande] ; Denis E. Kainov [Finlande, Norvège, Corée du Sud, Estonie] | Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins. |
| 001128 (2016) |
Hayley Davis [Royaume-Uni] ; Erna Raja [Japon] ; Kohei Miyazono [Japon] ; Yutaro Tsubakihara [Suède] ; Aristidis Moustakas [Suède] | Mechanisms of action of bone morphogenetic proteins in cancer. |
| 001191 (2016) |
Erik Nylander [Suède] ; Alfhild Grönbladh [Suède] ; Sofia Zelleroth [Suède] ; Shanti Diwakarla [Suède] ; Fred Nyberg [Suède] ; Mathias Hallberg [Suède] | Growth hormone is protective against acute methadone-induced toxicity by modulating the NMDA receptor complex. |
| 001246 (2016) |
Brendan R E. Ansell [Australie] ; Malcolm J. Mcconville [Australie] ; Louise Baker [Australie] ; Pasi K. Korhonen [Australie] ; Samantha J. Emery [Australie] ; Staffan G. Sv Rd [Suède] ; Robin B. Gasser [Australie] ; Aaron R. Jex [Australie] | Divergent Transcriptional Responses to Physiological and Xenobiotic Stress in Giardia duodenalis. |
| 001323 (2016) |
Joanna Parkinson [Suède] ; Bengt Hamrén [Suède] ; Maria C. Kjellsson [Suède] ; Stanko Skrtic [Suède] | Application of the integrated glucose-insulin model for cross-study characterization of T2DM patients on metformin background treatment. |
| 001767 (2015) |
Elizabeth V. Arkema [Suède] ; Jerker Jonsson [Suède] ; Eva Baecklund [Suède] ; Judith Bruchfeld [Suède] ; Nils Feltelius [Suède] ; Johan Askling [Suède] | Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments? |
| 001A23 (2014) |
Rikke M. R Ge [Suède] ; S Ren Klim ; Niels R. Kristensen ; Steen H. Ingwersen ; Maria C. Kjellsson | Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart. |
| 001A50 (2014) |
Christian Hove Rasmussen [Danemark] ; Rikke Meldgaard R Ge [Suède] ; Zhulin Ma [Danemark] ; Maria Thomsen [Danemark] ; Rannveig Linda Thorisdottir [Suède] ; Jian-Wen Chen [Suisse] ; Erik Mosekilde [Danemark] ; Morten Colding-J Rgensen [Danemark] | Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms. |
| 001C77 (2013) |
Alfhild Grönbladh [Suède] ; Jenny Johansson ; Mark M. Kushnir ; Jonas Bergquist ; Mathias Hallberg | The impact of nandrolone decanoate and growth hormone on biosynthesis of steroids in rats. |
| 001E06 (2013) |
Steve Choy [Suède] ; Emilie Hénin ; Jan-Stefan Van Der Walt ; Maria C. Kjellsson ; Mats O. Karlsson | Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model. |
| 001F35 (2013) |
Anne-Kristina Frobel [Suède] ; Mats O. Karlsson ; Janne T. Backman ; Kalle Hoppu ; Erik Qvist ; Paula Seikku ; Hannu Jalanko ; Christer Holmberg ; Ron J. Keizer ; Samuel Fanta ; Siv Jönsson | A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A. |
| 002F62 (2007) |
O. Nylander [Suède] ; M. Sjöblom | Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum. |
| 003031 (2007) |
Helena Jernberg-Wiklund [Suède] ; Kenneth Nilsson | Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I). |
| 003277 (2006) |
Kristina Magnusson [Suède] ; Mathias Hallberg ; Anna M S Kindlundh Högberg ; Fred Nyberg | Administration of the anabolic androgenic steroid nandrolone decanoate affects substance P endopeptidase-like activity in the rat brain. |
| 003442 (2005) |
Erik Uller S [Suède] ; Dominika Trzaska ; Joanna Arkusz ; Tove Ringerike ; Violetta Adamczewska ; Maciej Olszewski ; Janina Wycz Kowska ; Aurelia Walczak-Drzewiecka ; Khalid Al-Nedawi ; Gunnar Nilsson ; Urszula Białek-Wyrzykowska ; Maciej Stepnik ; Henk Van Loveren ; Rob J. Vandebriel ; Martinus L Vik ; Konrad Rydzy Ski ; Jarosław Dastych | Development of the "Cell Chip": a new in vitro alternative technique for immunotoxicity testing. |
| 003570 (2004) |
Sophia Thore [Suède] ; Oleg Dyachok ; Anders Tengholm | Oscillations of phospholipase C activity triggered by depolarization and Ca2+ influx in insulin-secreting cells. |
| 003C15 (2000) |
P. Johansson [Suède] ; A. Lindqvist ; F. Nyberg ; C. Fahlke | Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. |
